The Role of 5-Aminolevulinic Acid Fluorescence-Guided Surgery in Head and Neck Cancers: a Pilot Trial
Latest Information Update: 03 Apr 2024
At a glance
- Drugs Aminolevulinic acid (Primary)
- Indications Head and neck cancer
- Focus Diagnostic use
- 26 Mar 2024 Planned number of patients changed from 26 to 23.
- 26 Mar 2024 Planned End Date changed from 1 Jan 2024 to 1 Mar 2025.
- 26 Mar 2024 Planned primary completion date changed from 1 Jan 2024 to 1 Mar 2025.